NC S234

Requires the United States Food and Drug Administration therapeutic equivalence code to appear on the label of equivalent drug products dispensed by pharmacists.

Adds the FDA therapeutic equivalence code requirement to the existing standards that equivalent drug products must meet, alongside manufacturer name, distributor name, good manufacturing practices compliance, product identification marks, drug recall provisions, and outdated drug return provisions.

Removes an effective date restriction (January 1, 1982) from the requirement that oral solid dosage forms have identification marks or product names.

Becomes effective October 1, 2015.